Natco Pharma Ltd. announced that Dr. Jasti Sambasiva Rao, Director of the company resigned as a Director due to his personal preoccupations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,167 INR | +1.36% |
|
-2.82% | +43.82% |
28/05 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
28/05 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.82% | 2.51B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Jasti Sambasiva Rao Resigns as Director of Natco Pharma Limited